Introduction to current and future protein therapeutics: A protein engineering perspective von Carter, Paul J.

Volltext

Alternative molecular formats and therapeutic applications for bispecific antibodies von Spiess, Christoph, Zhai, Qianting, Carter, Paul J.

Volltext

Therapeutic antibodies for autoimmunity and inflammation von Chan, Andrew C, Carter, Paul J

Volltext

Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations von Heisler, Joel, Kovner, Daniel, Izadi, Saeed, Zarzar, Jonathan, Carter, Paul J

Volltext

Designing antibodies as therapeutics von Carter, Paul J., Rajpal, Arvind

Volltext

Next generation antibody drugs: pursuit of the 'high-hanging fruit' von Carter, Paul J., Lazar, Greg A.

Volltext

Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG1 antibody von Dai, Jing, Izadi, Saeed, Zarzar, Jonathan, Wu, Patrick, Oh, Angela, Carter, Paul J

Volltext

A strategy for risk mitigation of antibodies with fast clearance von Hötzel, Isidro, Theil, Frank-Peter, Bernstein, Lisa J., Prabhu, Saileta, Deng, Rong, Quintana, Leah, Lutman, Jeff, Sibia, Renuka, Chan, Pamela, Bumbaca, Daniela, Fielder, Paul, Carter, Paul J., Kelley, Robert F.

Volltext

Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies von Tilegenova, Cholpon, Izadi, Saeed, Yin, Jianping, Huang, Christine S., Wu, Jiansheng, Ellerman, Diego, Hymowitz, Sarah G., Walters, Benjamin, Salisbury, Cleo, Carter, Paul J.

Volltext

Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells von Joshi, Kamal Kishore, Phung, Wilson, Han, Guanghui, Yin, Yiyuan, Kim, Ingrid, Sandoval, Wendy, Carter, Paul J

Volltext

Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies von Tsai, Wen-Ting K, Li, Yinyin, Yin, Zhaojun, Tran, Peter, Phung, Qui, Zhou, Zhenru, Peng, Kun, Qin, Dan, Tam, Sien, Spiess, Christoph, Brumm, Jochen, Wong, Manda, Ye, Zhengmao, Wu, Patrick, Cohen, Sivan, Carter, Paul J

Volltext

Potent antibody therapeutics by design von Carter, Paul J

Volltext

Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics von Carter, Paul J, Quarmby, Valerie

Volltext

Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells von Dillon, Michael, Yin, Yiyuan, Zhou, Jianhui, McCarty, Luke, Ellerman, Diego, Slaga, Dionysos, Junttila, Teemu T, Han, Guanghui, Sandoval, Wendy, Ovacik, Meric A, Lin, Kedan, Hu, Zhilan, Shen, Amy, Corn, Jacob E, Spiess, Christoph, Carter, Paul J

Volltext

Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagers von Pinto, Sheena, Pahl, Jens, Schottelius, Arndt, Carter, Paul J., Koch, Joachim

Volltext

Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas von Gerber, Hans-Peter, Kung-Sutherland, May, Stone, Ivan, Morris-Tilden, Carol, Miyamoto, Jamie, McCormick, Renee, Alley, Stephen C., Okeley, Nicole, Hayes, Brad, Hernandez-Ilizaliturri, Francisco J., McDonagh, Charlotte F., Carter, Paul J., Benjamin, Dennis, Grewal, Iqbal S.

Volltext

Modulation of the high concentration viscosity of IgG 1 antibodies using clinically validated Fc mutations von Heisler, Joel, Kovner, Daniel, Izadi, Saeed, Zarzar, Jonathan, Carter, Paul J

Volltext

Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG 1 antibody von Dai, Jing, Izadi, Saeed, Zarzar, Jonathan, Wu, Patrick, Oh, Angela, Carter, Paul J

Volltext

Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97 von Smith, Leia M, Nesterova, Albina, Alley, Stephen C, Torgov, Michael Y, Carter, Paul J

Volltext

Antibody-drug conjugates for cancer therapy von Carter, Paul J, Senter, Peter D

Volltext